Company intelligence / Profile preview

Latinofarma

Barueri, São Paulo, Brazil

Ownership: Private
Development stage: Other

Overview

Latinofarma is a Brazilian pharmaceutical company specializing in the development, manufacturing, and commercialization of ophthalmic products. Founded in 1997 and acquired by the Cristália Group in 2008, the company has established itself as a key player in the Brazilian vision care market. Its portfolio includes a wide range of products such as lubricants, anti-glaucoma medications, antibiotics, and anti-inflammatory eye drops. The company provides both therapeutic and diagnostic solutions for ophthalmologists and patients. Latinofarma operates as a specialized business unit within the Cristália structure, leveraging advanced manufacturing capabilities to supply the domestic healthcare sector.

Therapeutic areas: ImmunologyOphthalmologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Latinofarma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Latinofarma.

Explore the full profile